Nathan A. Pennell MD, PhD, FASCO (@n8pennell) 's Twitter Profile
Nathan A. Pennell MD, PhD, FASCO

@n8pennell

Professor and thoracic oncologist, Vice Chair Clin Res @ClevelandClinic Cancer Inst, @ASCO #EdBook Editor in Chief, Dad, Steelers fan. All opinions mine. #LCSM

ID: 205280101

linkhttps://my.clevelandclinic.org/staff/8882-nathan-pennell calendar_today20-10-2010 14:26:30

21,21K Tweet

13,13K Takipçi

1,1K Takip Edilen

Nathan A. Pennell MD, PhD, FASCO (@n8pennell) 's Twitter Profile Photo

Not to steal the thunder from the oral session today, but this is the CROWN PFS curve, more or less flat between 2-5 years and still 60% progression free at 5 years! #ASCO24 #LCSM Is it worth the side effects of lorlatinib to turn ALK+ NSCLC into CML?

Not to steal the thunder from the oral session today, but this is the CROWN PFS curve, more or less flat between 2-5 years and still 60% progression free at 5 years! #ASCO24 #LCSM

Is it worth the side effects of lorlatinib to turn ALK+ NSCLC into CML?